Aspirin, even at low doses, decreases the risk of colorectal cancer
| Author : Pierre Allain
||Date : 2010-10-25
The usual intake of a non-steroidal anti-inflammatory drug, NSAID, including aspirin, is recognized as being able to reduce the risk of colorectal cancer.
A study published in Gut online September 15, 2010 shows that the prolonged use of aspirin, even at low doses, 75 mg daily, (as antiplatelet agent), reduced the risk of colorectal cancer by about 20% without modifying all cause mortality. Other NSAID have the same effect.
There are many analyzes concerning aspirin in Pharmacorama, see here.